Down Syndrome Obstructive Sleep Apnea

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age5-18
SponsorBrigham and Women's Hospital

About this trial

The purpose of this study is to assess whether oxygen supplementation during sleep improves working memory and other clinical and patient-reported outcomes among children who have Down Syndrome (DS) with moderate to severe Obstructive Sleep Apnea (OSA).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Ages 5.0 to 17.9 years at the time of screening

Children with OSA and obstructive apnea hypopnea index (OAHI) ≥5/hour.

Absence of clinically significant hypoxia defined as oxygen saturation <88% for 5 minutes or episodic desaturation to 60% as these levels would otherwise identify children eligible to routinely receive oxygen.

Oxygen saturation nadir >92% and

Disqualifiers

Current CPAP use with documented compliance(> 4 hrs/ night; > 70% of nights).

Oxygen saturation < 90% at rest during wakefulness.

Chronic daytime or nighttime use of supplemental oxygen.

Smoker in the child's bedroom.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Oxygen

    Drug

    Active nocturnal oxygen concentrator

Treatment groups

230 Participants
are divided into 2 treatment groups
Group A: Oxygen plus supportive care (OXT)Active comparator 1 intervention
Group B: Supportive care (SC)No intervention 0 interventions

Trial outcomes

Primary outcomes

1

Behavior Rating Inventory of Executive Function 2 (BRIEF2) working memory score

Change from baseline in the Behavior Rating Inventory of Executive Function 2 (BRIEF2) working memory score (BRIEF2wm). The score ranges from 35-90. A higher score is a worse outcome.

Time frame
Baseline and 6 months
2

Differential Ability Scales - 2nd Edition (DAS-II) T-score.

Change from baseline in the Differential Ability Scales - 2nd Edition (DAS-II) recognition of pictures (DAS2RoP) T-score. The score ranges from 10-90. A higher score is a better outcome.

Time frame
Baseline and 6 months

Secondary outcomes

1

Stanford-Binet Intelligence Scales, 5th edition (SB-5) Working Memory Total raw score

Change from baseline of Stanford-Binet Intelligence Scales, 5th edition (SB-5) Working Memory Total raw score. The score ranges from 0-64. A higher score is a better outcome.

Time frame
Baseline and 6 Months
2

Stanford-Binet Intelligence Scales, 5th edition (SB-5) Working Memory Verbal raw score

Change from baseline of Stanford-Binet Intelligence Scales, 5th edition (SB-5) Working Memory Verbal raw score. The score ranges from 0-30. A higher score is a better outcome.

Time frame
Baseline and 6 Months
3

Stanford-Binet Intelligence Scales, 5th edition (SB-5) Working Memory Non Verbal raw score

Change from baseline of Stanford-Binet Intelligence Scales, 5th edition (SB-5) Working Memory Non Verbal raw score. The score ranges from 0-34. A higher score is a better outcome.

Time frame
Baseline and 6 Months
4

Differential Ability Scales-2 (DAS-II) Recall of Digits Forward raw score

Change from baseline in Differential Ability Scales-2 (DAS-II) Recall of Digits Forward raw score. The score ranges from 0-38. A higher score is a better outcome.

Time frame
Baseline and 6 Months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Brigham and Women's Hospital

Lead sponsor

Children's Hospital Medical Center, Cincinnati

Collaborator

Children's Hospital of Philadelphia

Collaborator

Rainbow Babies and Children's Hospital

Collaborator

University of Michigan

Collaborator

Children's Hospital Los Angeles

Collaborator

Children's Hospital of The King's Daughters

Collaborator

Seattle Children's Hospital

Collaborator

University of Southern California

Collaborator

Boston Children's Hospital

Collaborator